[MIK Hot Spot_KHIDI] Juvic develops microneedle platform to deliver drugs without tissue damage or pain!

2020-04-29, Jane Lee Reporter

Juvic participated in the MIK Hot Spot (Made in Korea Online Exhibition) KHIDI and introduced its microneedle vaccine delivery platform with high hopes of meeting buyers and investors.

Juvic is developing a microneedle platform that delivers drugs into the epidermis without tissue damage or pain by supporting the drug on a microscopic structure that melts in the body. In particular, it is possible to effectively deliver drugs in the body while maintaining the activity of the drug through its own technology. Its microneedle platform is attracting attention for medical applications.

Microneedle electronic injecting microscope

Vaccines are in dire need for a new drug delivery system due to limitations such as refrigerated distribution and medical waste. To overcome these limitations, Juvic created a vaccine formulation that does not require refrigeration by centrifugal molding and developed a disposable microneedle applicator. Among the reasons why the actual microneedle was not expanded for medical use, the drug activity was poor, and it was difficult to deliver the quantity accurately. However, Juvic has been able to maintain the drug's activity with its own technology, and has developed a new concept of applicator to provide a new era in vaccine distribution.

Microneedle vaccine product

Based on these achievements, Juvic was selected by the government in November last year as a leading agency for a project to develop influenza vaccines into microneedle formulations. Professor Seong Baek-rin of Yonsei University, who is in charge of vaccine development in Juvic, has recently been elected as the head of the government's Vaccine Practical Technology Development Project, and is expected to provide a lot of support in developing new vaccine delivery technologies.

Example of microneedle vaccine application

Juvic is a company specializing in the development of medical microneedle established by Professor Jeong Hyung-il at the Department of Biotechnology at Yonsei University. Professor Jeong has already transferred the initial technology to RAPHAS that was listed on KOSDAQ last year and successfully commercialized the microneedle business in the cosmetics field. Professor Jeong and the research team is the largest and highest level of microneedle development team in Korea.

Juvic is a company specializing in the development of medical microneedle established by Professor Jeong Hyung-il at the Department of Biotechnology at Yonsei University. Professor Jeong has already transferred the initial technology to RAPHAS that was listed on KOSDAQ last year and successfully commercialized the microneedle business in the cosmetics field. Professor Jeong and the research team is the largest and highest level of microneedle development team in Korea.

In emergency situations such as the recent COVID-19 pandemic, there is a need for a non-face-to-face inoculation solution that does not require refrigeration nor additional medical personnel, so the new vaccine solution of Juvic is recognized as a very suitable form in preparation for a national epidemic disaster. Professor Jeong said, "Juvic's technology in formulation, manufacturing, and delivery have been proven to be successful through the implementation of government projects, and we are proceeding with government support for the development of influenza vaccine formulations. We will do our best to set up a platform to efficiently distribute the necessary vaccines in the future so that the government can quickly supply the vaccines to the public even in a disaster."

The products and services of the major companies of KHIDI Health Industry Startup Innovation Center in the MIK Hot Spot (Made in Korea Online Exhibition) will also be displayed in BIO KOREA 2020. Asia's biggest bio convention BIO KOREA 2020 co-organized by KHIDI and Chungbuk Province and sponsored by MOHW will be open online due to the COVID-29 pandemic on May 18-23. Virtual exhibition halls, conference, and business forums will be operated, and the companies will be promoting their competitiveness. Also, with video meetings, businesses between overseas speakers, buyers, and domestic and foreign participating companies will be made. To date, more than 160 companies have applied for the virtual exhibition booth at BIO KOREA 2020. Companies wishing to participate can apply through the web page or email by Apr. 30.

The global news network AVING News has begun holding the MIK Hot Spot (Made in Korea Online Exhibition) to help small and medium-sized companies enter the market and attract investment 365 days a year. AVING News has been running online exhibitions since 2005 and had 975 online exhibitions so far. Its YouTube online exhibition has placed itself as Korea's largest online exhibition hall that opens with 19,000 videos (booths) with more than 800,000 visits per month which means more than 10 million visits per year.

The MIK Hot Spot online exhibition is scheduled to be held regularly according to the field, target market, and participating institutions, and it will be presented as a new type of online business by transforming the know-hows and values of the participating companies according to the trend. Companies that want to participate can apply and apply through the marketing support projects from supporting institutions in the local governments. Refer to the institutions for more information.

→ Go to MIK Hot Spot (Made in Korea Online Exhibition) special page

→ Go to MIK Hot Spot (Made in Korea Online Exhibition) information page

[ⓒ avingnews, Prohibition of reprinting and redistribution prohibited]